Effect of rutin from tartary buckwheat sprout on serum glucose-lowering in animal model of type 2 diabetes

Acta Pharm. 2016 Jun 1;66(2):297-302. doi: 10.1515/acph-2016-0021.

Abstract

This study investigates the anti-diabetic effects of rutin from tartary buckwheat sprout in type 2 diabetes mouse model. The rutin content in tartary buckwheat sprout (TBS) is five times higher than that found in common buckwheat sprout (CBS) as evident from high-performance liquid chromatography analysis. Administration of either rutin or TBS ethanolic extract to diabetes mice decreased the serum glucose level significantly. Rutin down-regulated the expression levels of protein-tyrosine phosphatase 1B; it is negative regulator of insulin pathway, both transcriptionally and translationally in myocyte C2C12 in a dose-dependent manner. In conclusion, rutin can play a critical role in down-regulation of serum glucose level in type 2 diabetes.

MeSH terms

  • 3T3-L1 Cells
  • Animals
  • Biomarkers / blood
  • Blood Glucose / drug effects*
  • Blood Glucose / metabolism
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / genetics
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Down-Regulation
  • Fagopyrum / chemistry
  • Hypoglycemic Agents / isolation & purification
  • Hypoglycemic Agents / pharmacology*
  • Mice
  • Mice, Inbred C57BL
  • Myoblasts, Skeletal / drug effects
  • Myoblasts, Skeletal / enzymology
  • Phytotherapy
  • Plants, Medicinal
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1 / genetics
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1 / metabolism
  • Rutin / isolation & purification
  • Rutin / pharmacology*
  • Seedlings
  • Time Factors

Substances

  • Biomarkers
  • Blood Glucose
  • Hypoglycemic Agents
  • Rutin
  • Protein Tyrosine Phosphatase, Non-Receptor Type 1
  • Ptpn1 protein, mouse